Wellcome Genome Campus has appointed Gensler to design the first life sciences buildings in the new expansion of its site in Hinxton, South Cambridgeshire.
The development, which recently secured planning approval, comprises two purpose-built life sciences buildings providing more than 200,000 sq ft.
The Gateway Research & Translation Buildings will be a gateway to the new campus and feature incubator and accelerator spaces alongside amenities including a pub and a café.
Nathan Morgan, project director and global sciences leader at Gensler, said: “We are excited to partner with the Wellcome Genome Campus to design the first life sciences buildings in the expansion of its site. This is a significant step forward in Wellcome Genome Campus realising the vision of a globally significant science destination, with strong connections to the local environment and community.”
Robert Evans, chief executive of Wellcome Genome Campus, added: “We are delighted to gain approval for these striking new buildings, which should start on site later this year, as part of our expansion phase one. We are providing world-class facilities for translational research and development, supporting growth and enabling new partnerships and breakthroughs that benefit people everywhere.”
The project team includes David Lock Associates, AKT II, Churchman Thornhill Finch, Scotch Partners and CB3.
